Introduction
Osteopetrosis is a rare congenital genetic disorder characterized by increased bone density due to impaired bone resorption by osteoclasts. [1] The autosomal dominant (AD) form of osteopetrosis is usually asymptomatic. It is diagnosed incidentally or may exhibit mild symptoms in late childhood or adult life, but is compatible with long term survival. [2] Autosomal recessive (AR) malignant infantile osteopetrosis (MIOP), Online Mendelian Inheritance in men (OMIM)(259700), is uncommon however, it is a severe fatal disorder with an average incidence of 1:200,000-1:300,000. [1] This disease is caused by defector mutation in gene and 14 out of 20 MIOP patients had gene mutations. [1] 
Discussion
MIOP is a AR form which if untreated has a fatal outcome. [3] The diagnosis of MIOP is based on typical clinical and hematological parameters and characteristic radiological changes of increased bone density. The characteristic radiological feature of osteopetrosis is generalized sclerosis of bone. [2] Our child had classical characteristics of MIOP and increased bone density was found in all the bones. Most of the cases present within 1 st year of life. [1, 3] The age at the time of diagnosis was between 3 months and 18 months in a study by
Phadke et al. [2] The mean age at the time of diagnosis was 3.9 months (range 15 days to 9.5 months) in a study by Mazzolari et al. [1] Out of 8 children 7 were diagnosed after 6 months of age in a study from India. [3] Usually, MIOP presents with anemia, thrombocytopenia, hepatosplenomegaly, visual impairment due to optic atrophy, and deafness within a year of life. [1, 2, 4] The major clinical features derived from bony overgrowth of the marrow space and compression of optic and auditory nerve. [1] The commonest clinical presentation was due to optic nerve compression in various studies. [1, 4] Even
Phadke et al. Observed optic atrophy as the common finding in their cases. [3] However, the most common presenting symptoms were pallor and listlessness in anotherstudy [2] However, our child presented with anemia and gross hepatosplenomegaly at 2 months 15 days but without vision defects. The risk of developing a visual defect in the 1 st year of life is about 75% and surgical decompression of optic nerve may restore vision. [2] The hematological manifestations in MIOP are due to obliteration of marrow cavity leading to leukoerythroblastic bonemarrow. [2] Cells of promyeloid series may be found due to ineffective marrow function, which was found in our case. Hepatosplenomegaly develops because of extramedullary hematopoiesis.
Hypersplenism may lead to thrombocytopenia, who may present with bleeding similar to our case. Anemia and thrombocytopenia is a constant feature in most of the studies. [2, 3] The risk of developing hematological impairment in the 1 st year of life is about 75% and its onset within 3 months of life is indicative of a poor outcome. [4] MIOP should be considered in the differential diagnosis of anemia with hepatosplenomegaly in an infant otherwise he/she may be wrongly diagnosed as a leukemia or other hemolytic anemia. [2] Increased risk of infections because of unrecognized immunologic abnormalities in patients with MIOP was observed. [1] Infact our baby presented to us with bronchopneumonia. In a study by Fattore et al.
Bone AP was low in AD variety of osteopetrosis whereas it was high in AR variety. [5] Our child also had A P values of 3500U/L and elevation of LDH. However, other studies did not show much elevation of AP. [2, 3] AP (mean: 921 U/L; range: 156-2583 U/L) were markedly increased and they were within the normal range only in four subjects in a study by Mazzolari et al. [1] In a study by Srinivasan et al. Symptomatic hypocalcemia was observed in the 1 st month of life in 8 infants with MIOP [6] but our child had normal calcium levels. In a study by Phadke et al. None of them had hypocalcemia and only one had alkaline phosphatase levels >1500 U/L. [2] Clinical outcome with paratharmone, calcitrol, interferon gamma and prednisone therapy has been found to be inconsistent and variable. [1, 2] An accurate diagnosis is essential in view of availability of curative treatment (Bon emarrow transplant) and for genetic counseling as the risk of recurrence in siblings is 25%. [1, 2] Most of the children die during infancy or early child hood without curative treatment by bonemarrow transplantation. [3] To conclude MIO Prema insun recognized as a cause of anemia with hepatospleenomegaly in less than 6 months of life and often results in diagnostic delay. Early diagnosis is important in the context of bonemarrow transplantation.
